In Parkinson’s disease, GPR37 misprocessing contributes to ER stress and dopaminergic neurodegeneration, while in multiple sclerosis and stroke, its dysregulation alters myelin repair and neurogenic responses. Here, GPR37 is linked to stroke disorder.